Atlas of Liquid Biopsy Circulating Tumor Cells and Other Rare Cells in Cancer Patients’ Blood

This book provides a wealth of images and extensive information on circulating tumor cells (CTCs) and other cells usually observed in blood from patients with cancer, such as giant macrophages, and circulating tumor microemboli (CTM). The field of “liquid biopsy” began with the analysis of CTCs in t...

Full description

Bibliographic Details
Other Authors: Chinen, Ludmilla Thomé Domingos (Editor)
Format: eBook
Language:English
Published: Cham Springer International Publishing 2021, 2021
Edition:1st ed. 2021
Subjects:
Online Access:
Collection: Springer eBooks 2005- - Collection details see MPG.ReNa
LEADER 02729nmm a2200277 u 4500
001 EB001993838
003 EBX01000000000000001156740
005 00000000000000.0
007 cr|||||||||||||||||||||
008 210608 ||| eng
020 |a 9783030698799 
100 1 |a Chinen, Ludmilla Thomé Domingos  |e [editor] 
245 0 0 |a Atlas of Liquid Biopsy  |h Elektronische Ressource  |b Circulating Tumor Cells and Other Rare Cells in Cancer Patients’ Blood  |c edited by Ludmilla Thomé Domingos Chinen 
250 |a 1st ed. 2021 
260 |a Cham  |b Springer International Publishing  |c 2021, 2021 
300 |a XII, 204 p. 99 illus. in color  |b online resource 
505 0 |a Introduction -- Typical Circulating Tumor Cells (CTCs) -- Atypical CTCs -- Endothelial Cells -- Circulating Tumor Microemboli -- Giant Macrophages -- Cells of Undetermined Meaning 
653 |a Pathology 
653 |a Oncology   
653 |a Oncology 
653 |a Pathology 
041 0 7 |a eng  |2 ISO 639-2 
989 |b Springer  |a Springer eBooks 2005- 
856 4 0 |u https://doi.org/10.1007/978-3-030-69879-9?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 616.994 
520 |a This book provides a wealth of images and extensive information on circulating tumor cells (CTCs) and other cells usually observed in blood from patients with cancer, such as giant macrophages, and circulating tumor microemboli (CTM). The field of “liquid biopsy” began with the analysis of CTCs in the early 2000s. In the beginning, molecular techniques were developed to detect these cells in the blood. However, it has since become clear that CTCs initially require a cytopathological analysis to be detected without false positive and negative results. After detection, molecular analysis can be subsequently performed. Cancer is an important cause of mortality, especially when detected in late stages. Even with all the advances that have been made in its treatment, cancer is still challenging, as many patients do not respond to any therapy. Many health agencies have considered early diagnosis as a feasible tool. In this context, it is of the utmost importance to know the morphology and characteristics of CTCs to determine a correct diagnosis. Currently much of the scientific community is committed to expanding our knowledge of CTCs, and this work makes a valuable contribution, presenting many cell images from patients with several types of cancer, in different stages of disease, and after receiving various treatments. The Atlas of Liquid Biopsy: Circulating Tumor Cells and Other Rare Cells in Cancer Patients’ Blood is an essential reference guide for all physicians, biologists, biomedics, and professionals working at hospitals, clinics and research centers